302 related articles for article (PubMed ID: 26079345)
1. Practice Patterns and Outcomes Associated With Choice of Initial Vasopressor Therapy for Septic Shock.
Fawzy A; Evans SR; Walkey AJ
Crit Care Med; 2015 Oct; 43(10):2141-6. PubMed ID: 26079345
[TBL] [Abstract][Full Text] [Related]
2. Association Between US Norepinephrine Shortage and Mortality Among Patients With Septic Shock.
Vail E; Gershengorn HB; Hua M; Walkey AJ; Rubenfeld G; Wunsch H
JAMA; 2017 Apr; 317(14):1433-1442. PubMed ID: 28322415
[TBL] [Abstract][Full Text] [Related]
3. Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).
Póvoa PR; Carneiro AH; Ribeiro OS; Pereira AC;
Crit Care Med; 2009 Feb; 37(2):410-6. PubMed ID: 19114885
[TBL] [Abstract][Full Text] [Related]
4. Association Between Hospital Case Volume of Sepsis, Adherence to Evidence-Based Processes of Care and Patient Outcomes.
Fawzy A; Walkey AJ
Crit Care Med; 2017 Jun; 45(6):980-988. PubMed ID: 28350646
[TBL] [Abstract][Full Text] [Related]
5. Effect of norepinephrine on the outcome of septic shock.
Martin C; Viviand X; Leone M; Thirion X
Crit Care Med; 2000 Aug; 28(8):2758-65. PubMed ID: 10966247
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock.
Patel GP; Grahe JS; Sperry M; Singla S; Elpern E; Lateef O; Balk RA
Shock; 2010 Apr; 33(4):375-80. PubMed ID: 19851126
[TBL] [Abstract][Full Text] [Related]
7. Relative Bradycardia in Patients With Septic Shock Requiring Vasopressor Therapy.
Beesley SJ; Wilson EL; Lanspa MJ; Grissom CK; Shahul S; Talmor D; Brown SM
Crit Care Med; 2017 Feb; 45(2):225-233. PubMed ID: 27618277
[TBL] [Abstract][Full Text] [Related]
8. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.
Hall LG; Oyen LJ; Taner CB; Cullinane DC; Baird TK; Cha SS; Sawyer MD
Pharmacotherapy; 2004 Aug; 24(8):1002-12. PubMed ID: 15338849
[TBL] [Abstract][Full Text] [Related]
9. Dopamine therapy in septic shock: detrimental effect on survival?
Boulain T; Runge I; Bercault N; Benzekri-Lefevre D; Wolf M; Fleury C
J Crit Care; 2009 Dec; 24(4):575-82. PubMed ID: 19327324
[TBL] [Abstract][Full Text] [Related]
10. Controversies regarding choice of vasopressor therapy for management of septic shock in animals.
Silverstein DC; Beer KA
J Vet Emerg Crit Care (San Antonio); 2015; 25(1):48-54. PubMed ID: 25655726
[TBL] [Abstract][Full Text] [Related]
11. Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials.
Vasu TS; Cavallazzi R; Hirani A; Kaplan G; Leiby B; Marik PE
J Intensive Care Med; 2012; 27(3):172-8. PubMed ID: 21436167
[TBL] [Abstract][Full Text] [Related]
12. Hydrocortisone Therapy in Catecholamine-Resistant Pediatric Septic Shock: A Pragmatic Analysis of Clinician Practice and Association With Outcomes.
Nichols B; Kubis S; Hewlett J; Yehya N; Srinivasan V
Pediatr Crit Care Med; 2017 Sep; 18(9):e406-e414. PubMed ID: 28658197
[TBL] [Abstract][Full Text] [Related]
13. Vasopressor use in septic shock: an update.
Leone M; Martin C
Curr Opin Anaesthesiol; 2008 Apr; 21(2):141-7. PubMed ID: 18443479
[TBL] [Abstract][Full Text] [Related]
14. A comparison of initial monotherapy with norepinephrine versus vasopressin for resuscitation in septic shock.
Daley MJ; Lat I; Mieure KD; Jennings HR; Hall JB; Kress JP
Ann Pharmacother; 2013 Mar; 47(3):301-10. PubMed ID: 23447481
[TBL] [Abstract][Full Text] [Related]
15. Incidence of hypotension according to the discontinuation order of vasopressors in the management of septic shock: a prospective randomized trial (DOVSS).
Jeon K; Song JU; Chung CR; Yang JH; Suh GY
Crit Care; 2018 May; 22(1):131. PubMed ID: 29784057
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of Vasopressin Use for Adults with Septic Shock.
Vail EA; Gershengorn HB; Hua M; Walkey AJ; Wunsch H
Ann Am Thorac Soc; 2016 Oct; 13(10):1760-1767. PubMed ID: 27404213
[TBL] [Abstract][Full Text] [Related]
17. Continuation of Statin Therapy and Vasopressor Use in Septic Shock.
Zechmeister C; Hurren J; McNorton K
Ann Pharmacother; 2015 Jul; 49(7):790-5. PubMed ID: 25896127
[TBL] [Abstract][Full Text] [Related]
18. Management of septic shock with a norepinephrine-based haemodynamic algorithm.
Hernandez G; Bruhn A; Romero C; Javier Larrondo F; De La Fuente R; Castillo L; Bugedo G
Resuscitation; 2005 Jul; 66(1):63-9. PubMed ID: 15993731
[TBL] [Abstract][Full Text] [Related]
19. Global utilization of low-dose corticosteroids in severe sepsis and septic shock: a report from the PROGRESS registry.
Beale R; Janes JM; Brunkhorst FM; Dobb G; Levy MM; Martin GS; Ramsay G; Silva E; Sprung CL; Vallet B; Vincent JL; Costigan TM; Leishman AG; Williams MD; Reinhart K
Crit Care; 2010; 14(3):R102. PubMed ID: 20525247
[TBL] [Abstract][Full Text] [Related]
20. Activated protein C and hospital mortality in septic shock: a propensity-matched analysis.
Lindenauer PK; Rothberg MB; Nathanson BH; Pekow PS; Steingrub JS
Crit Care Med; 2010 Apr; 38(4):1101-7. PubMed ID: 20154607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
